Warts are common epidermal growths caused by human papillomavirus that often cause
significant discomfort and embarrassment. Current treatment options include topical …

Background Without clear evidence, selecting among the existing immunotherapeutic
options for warts remains challenging. Objective Through network meta-analyses, we aimed …

Background: Verruca vulgaris (viral warts) is a fairly common condition with a plethora of
treatment options having variable success rates. Recalcitrant warts are refractory to …

The Genital warts are common sexually transmitted diseases caused by definite types of
human papillomavirus. There are many strategies for the treatment of genital wart and …

Cutaneous warts are a common pediatric complaint with modest response to first‐line
treatments. Warts are a manifestation of human papillomavirus (HPV) infection and are …

Introduction The treatment of recalcitrant nongenital cutaneous warts has always been
challenging for dermatologists as they often recur and relapse. Multiple treatment options …

Background Intralesional immunotherapy has been reported to be effective for warts and to
show good safety profiles, but this has not yet been systematically studied. Aims To …

Intralesional (IL) vitamin D3 is an emerging treatment for cutaneous warts. However, its
effectiveness and exact mechanism is not fully evaluated. We aimed to compare the efficacy …

Warts are regularly treated by dermatologists, and while many respond readily to first-line
treatments, others may represent a therapeutic challenge. Large, deep, numerous, and …

Background: Present day therapeutic modalities for viral warts are mostly ablative in nature,
limited by high recurrence rates and are unsuitable for numerous lesions. Immunotherapy …